linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Arihant Superstructures Ltd.
 
Source DateBoard Meeting DateDetails
01 Feb 202610 Feb 2026 Stock Split & Quarterly Results
06 Nov 202512 Nov 2025 Stock Split & Quarterly Results
06 Aug 202512 Aug 2025 Quarterly Results & A.G.M. & Inter alia, to consider and approve:- (a) To consider and discuss the appointment of Mr. Udit Kasera as Chief Financial Officer (CFO) of the company. (b) To consider and approve the standalone and consolidated Unaudited Financial Statements of the company for the quarter ended June 30, 2025 along with the Limited Review Report thereon. (c) To review and approve the Related Party Transactions/Transactions under Omnibus Approval of the Company for the quarter ended June 30, 2025. (d) To take note of the Secretarial Audit Report issued by M/s D. A. Kamat & Co, Company Secretaries, Mumbai for the Financial Year 2024-25. (e) To consider and approve appointment of Secretarial Auditor of the Company for the financial year 2025-26. (f) To consider and approve the Directors Report, along with the Annexures U/s 134 of the Companies Act, 2013. (h) To decide the date of Annual General Meeting of the Company for Financial Year ending March 31, 2025 and decide on matters in respect of e-voting, Notice of AGM and related matters.
16 May 202524 May 2025 Audited Results & Final Dividend
20 Mar 202525 Mar 2025 Inter-alia to: (a) Taking permission from the board for seeking approval of members of the Company by way of Special Resolution for Regularization of appointment of Mr. Sridhar Ramachandran (DIN: 07706213) from additional Independent Director to Independent Director. (b) To approve the draft Notice of Postal Ballot incorporating the proposed resolution and explanatory statement and to undertake all the necessary steps thereof.
27 Jan 202503 Feb 2025 Quarterly Results
18 Oct 202426 Oct 2024 Quarterly Results
01 Aug 202409 Aug 2024 Quarterly Results
09 May 202415 May 2024 Quarterly Results & Final Dividend & Audited Results
20 Mar 202423 Mar 2024 Inter alia, to consider and approve: - To consider and approve fund raising by way issue of securities including securities and warrants convertible into non convertible debt instruments Subject to approval of Board of Directors and approvals from the other regulatory authorities as may be required
16 Feb 202424 Feb 2024 Inter alia, to consider the following proposal: - 1) To take note of the performance evaluation of the Independent Directors for the financial year 2023-24 2) To consider and discuss the appointment of Ms. Tasneem Marfatia as company secretary and compliance officer of the company. 3) To take note of the terms of appointment of the Directors and Key Managerial Personnel and evaluation of increase / decrease in remuneration as per the performance evaluation submitted and taken on table by the board. 4) To consider any other matter with the permission of the Chair.
02 Feb 202412 Feb 2024 Quarterly Results
31 Oct 202307 Nov 2023 Quarterly Results & Inter alia, to consider:- b) To consider and approve the appointment of Chairman of Audit and Nomination & Remuneration Committee c) To consider and approve fund raising by way of issue of share warrants or any other securities through private placement/preferential issue or through any other permissible mode and/ or combination thereof as may be considered appropriate subject to approval from the shareholders and approvals from the other regulatory authorities as may be required.
04 Aug 202311 Aug 2023 Quarterly Results (Revised)
31 Jul 202310 Aug 2023 A.G.M. & Quarterly Results
22 May 202322 May 2023 Quarterly Results(Cancelled)
15 May 202322 May 2023 Quarterly Results & Final Dividend
27 Jan 202304 Feb 2023 Quarterly Results
04 Nov 202212 Nov 2022 Quarterly Results
15 Jul 202223 Jul 2022 A.G.M. & Quarterly Results
Page 1 of 7
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.